Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.3442 (-8.65%) ($0.3442 - $0.3442) on Fri. Apr. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.58% (three month average) | RSI | 37 | Latest Price | $0.3442(-8.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -7.1% a day on average for past five trading days. | Weekly Trend | ANPC declines -5.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) EWI(83%) PAVE(81%) XLK(77%) EWP(71%) QQQ(70%) | Factors Impacting ANPC price | ANPC will decline at least -5.29% in a week (0% probabilities). SHY(-37%) TIP(-28%) BNDX(-27%) BND(-23%) VCSH(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.29% (StdDev 10.58%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-16.87(-5001.22%) | Resistance Level | $0.44 | 5 Day Moving Average | $0.39(-11.74%) | 10 Day Moving Average | $0.43(-19.95%) | 20 Day Moving Average | $0.44(-21.77%) | To recent high | -62.3% | To recent low | 0% | Market Cap | $3m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |